Skip to main content

Table 1 Demographic and baseline characteristics of both groups

From: Early functional outcome after IV rTPA administration in Egyptian acute ischemic stroke patients

  Group I Group II X2 value P value
N % N %  
Age 60.24 ± 9.37   58.81 ± 13.31    0.37
Male 51 68.0 62 54.4 3.487 0.062
Hypertension 49 65.3 62 54.4 2.237 0.135
Cardiac diseases IHD$ 24 32 31 27.2 0.507 0.477
RHD 5 6.7 7 6.1 0.021 1
AF 12 16 28 24.6 1.987a 0.159
Smoker 24 32 27 23.7 1.588 0.208
Cerebrovascular ischemic event Stroke 12 16 25 21.9 2.636 0.450
TIA 5 6.7 3 2.6
TIA + stroke 1 1.3 2 1.8
Diabetes Mellitus 27 36 40 35.1 0.016 0.898
Hyperlipidemia 28 37.3 35 30.7 0.882 0.348
Stroke Severity Mild (NIHSS|| 0–8) 21 28.0 43 37.7 1.920 0.383
Moderate (NIHSS|| 9–15) 37 49.3 48 42.1
Severe (NIHSS|| ≥ 16) 17 22.7 23 20.2
TOAST classification Large vessel 15 20.0 20 17.5 0.187 0.6658
Cardioembolic 24 32.0 44 38.6 0.851 0.3563
small vessel 12 16.0 15 13.2 0.288 0.5917
Others 24 32.0 35 30.7 0.035 0.8507
OCSP classification TACS** 35 46.7 34 29.8 5.545 0.0185*
PACS†† 24 32.0 60 52.6 7.734 0.0054*
LACS‡‡ 14 18.7 15 13.2 1.046 0.3065
POCS§§ 2 2.7 5 4.4 0.363 0.5471
  1. *P value ˂0.05 is significant, $ischemic heart disease, rheumatic heart disease, atrial fibrillation, § transient ischemic attack, ||National institute of health, Oxfordshire Community Stroke Project, **total anterior circulation syndrome, ††partial anterior circulation syndrome, ‡‡lacunar syndrome, §§posterior circulation syndrome